185 related articles for article (PubMed ID: 33279656)
1. Reporting and design of randomized controlled trials for COVID-19: A systematic review.
Dillman A; Park JJH; Zoratti MJ; Zannat NE; Lee Z; Dron L; Hsu G; Smith G; Khakabimamaghani S; Harari O; Thorlund K; Mills EJ
Contemp Clin Trials; 2021 Feb; 101():106239. PubMed ID: 33279656
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials.
Zhao MZ; Zhao C; Tu SS; Wei XX; Shang HC
J Integr Med; 2021 Jul; 19(4):317-326. PubMed ID: 33789839
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Transparency and reporting characteristics of COVID-19 randomized controlled trials.
Kapp P; Esmail L; Ghosn L; Ravaud P; Boutron I
BMC Med; 2022 Sep; 20(1):363. PubMed ID: 36154932
[TBL] [Abstract][Full Text] [Related]
6. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
7. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
8. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
9. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement.
Yin Y; Shi F; Zhang Y; Zhang X; Ye J; Zhang J
PLoS One; 2021; 16(9):e0257093. PubMed ID: 34555033
[TBL] [Abstract][Full Text] [Related]
11. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
12. Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
Janiaud P; Hemkens LG; Ioannidis JPA
Can J Cardiol; 2021 Sep; 37(9):1353-1364. PubMed ID: 34077789
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Research Waste Among Randomized Clinical Trials in Gastric Cancer.
Lu J; Xu BB; Shen LL; Wu D; Xue Z; Zheng HL; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM; Zheng CH; Li P
JAMA Netw Open; 2021 Sep; 4(9):e2124760. PubMed ID: 34533573
[TBL] [Abstract][Full Text] [Related]
15. The methodological quality of 176,620 randomized controlled trials published between 1966 and 2018 reveals a positive trend but also an urgent need for improvement.
Vinkers CH; Lamberink HJ; Tijdink JK; Heus P; Bouter L; Glasziou P; Moher D; Damen JA; Hooft L; Otte WM
PLoS Biol; 2021 Apr; 19(4):e3001162. PubMed ID: 33872298
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis for COVID-19: a systematic review.
Smit M; Marinosci A; Agoritsas T; Calmy A
Clin Microbiol Infect; 2021 Apr; 27(4):532-537. PubMed ID: 33476807
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 trials: declarations of data sharing intentions at trial registration and at publication.
Li R; von Isenburg M; Levenstein M; Neumann S; Wood J; Sim I
Trials; 2021 Feb; 22(1):153. PubMed ID: 33602275
[TBL] [Abstract][Full Text] [Related]
18. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications.
Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M
J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
Gianola S; Jesus TS; Bargeri S; Castellini G
PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
[TBL] [Abstract][Full Text] [Related]
20. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
